PET-MF

Clinical trials for PET-MF explained in plain language.

Never miss a new study

Get alerted when new PET-MF trials appear

Sign up with your email to follow new studies for PET-MF, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for myelofibrosis patients who fail current therapies

Disease control Recruiting now

This early-stage study tests an experimental pill, AJ1-11095, in people with a bone marrow cancer called myelofibrosis. Participants must have already tried a standard JAK2 inhibitor without success. The main goals are to check the drug's safety and find the best dose for future …

Matched conditions: PET-MF

Phase: PHASE1 • Sponsor: Ajax Therapeutics, Inc. • Aim: Disease control

Last updated May 13, 2026 16:03 UTC

PET-MF

Get alerted when new PET-MF trials appear

New hope for myelofibrosis patients who fail current therapies